Apatinib With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2- Advanced Breast Cancer

Condition:   Breast Cancer Metastatic Cancer Interventions:   Drug: Apatinib;   Drug: Dalpiciclib;   Drug: Fulvestrant/AI Sponsor:   Fudan University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials